Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

Conditions:   Diabetes Mellitus, Type 2;   Renal Insufficiency, ChronicInterventions:   Drug: Sitagliptin;   Drug: Glipizide;   Drug: Placebo for Sitagliptin;   Drug: Placebo for GlipizideSponsor:   Merck Sharp & Dohme Corp.Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials